È­¼øÀü³²´ëº´¿ø ¹è¿ì±Õ ±³¼ö, GSK Çмú»ó ¼ö»ó

´º½ºÀÏÀÚ: 2010³â06¿ù15ÀÏ 00½Ã00ºÐ

È­¼øÀü³²´ëÇб³º´¿ø Á¾¾ç³»°ú ¹è¿ì±Õ ±³¼ö(»çÁø)°¡ Áö³­ 10~11ÀÏ ¼­¿ï ·Ôµ¥È£ÅÚ¿¡¼­ °³ÃÖµÈ Á¦ 36ȸ ´ëÇѾÏÇÐȸ Çмú´ëȸ¿¡¼­ ‘ÀüÀ̼º ´ëÀå¾Ï¿¡¼­ ¸®³î·¹»ê¿¡ Ç÷ç¿À·Î¿ì¶ó½Ç °áÇսà Ç׾ϻó½ÂÈ¿°ú(Enhanced anticancer effect of 5-fluorouracil loaded into thermoresponsive conjugated linoleic acid-incorporated poloxamer hydrogel on metastatic colon cancer models)’¶ó´Â ÁÖÁ¦·Î ±¸¿¬ ¹ßÇ¥ ÈÄ ¿ì¼ö³í¹®¿¡ ¼±Á¤µÆ´Ù.

ÀÌ ¿¬±¸´Â Áö³­ÇØ ‘2009 GJ-NST ±¹Á¦È¸ÀÇ’¿¡¼­ ÃÖ¿ì¼öÆ÷½ºÅÍ»óÀ» ¼ö»óÇÑ ¹Ù ÀÖ´Ù.


ÀÌ ´º½ºÅ¬¸®ÇÎÀº BKT´º½º{www.bktimes.net}¿¡¼­ ¹ßÃéµÈ ³»¿ëÀÔ´Ï´Ù.